14.9.74
|
CVA Reading 1, p.37, pl. 22, no.27; Lemos 1991 p.241, no.230; Villing et al 2013-2015
(ORC) GD.0246 phase 2;
|
|
26.2.54
|
Lemos 1991 p.315, no.1353; CVA ReadingI, p.37, pl.22, no.28; Villing et al 2013-2015 (ORC) GD.2118, phase 2;
|
|
26.2.60
|
CVA Reading 1, p.37, pl.23, no.2a-b; Lemos 1991 p.303, no.1113, pl.153; Villing et al 2013-2015 (ORC) GD.0866 phase 2;
|
|
26.2.61
|
CVA Reading 1, p.37, pl.23, no.3a-b; Villing et al 2013-2015 (ORC) GD.1522 phase 2; Lemos 1991 p.303, no.1115, pl.153;
|
|
26.2.62
|
CVA Reading 1, p.37, pl.23, no.4a-b; Lemos 1991 p.292, no.912, pl.121; Villing et al (2013-2015) ORC GD.1214 phase 2;
|
|
26.2.63
|
CVA Reading 1,p.37,pl.23, no.5; Lemos 1991 p.233, pl.6, no.67; Villing et al 2013-2015 (ORC) GD.0353 phase2
|
|
26.2.64
|
CVA Reading 1, p.37,pl.23. no.6a-b; Lemos 1991 p.265, no.578, pl.73; Villing et al 2013-2015 (ORC) GD.0627 phase 2;
|
|
26.2.65
|
CVA Reading 1,p.37, pl.23, no.7a-b; Lemos 1991 p.303, no. 1116, pl.153; Villing et al 2013-2015 (ORC) GD.1521 phase 2;
|
|
26.2.66
|
CVA Reading 1, p.37, pl.23, no.8; Lemos 1991 p.306, no.1225, pl.159; Villing et al 2013-2015 (ORC) GD.2025 phase 2;
|
|
26.2.67
|
CVA Reading 1, p.37, pl.23, no.9a-b; Lemos 1991 p. 303, no.1114, pl.153; Villing et al 2013-2015 (ORC) GD.0668 phase 2;
|
|
26.2.68
|
CVA Reading 1, p.38, pl.23, no.10a-b; Lemos 1991 p.306, no. 1226, pl.159; Villing et al 2013-2015 (ORC) GD.1213 phase 2;
|
|
26.2.69
|
CVA Reading 1,p.38, pl. 23., no,11a-b; Lemos 1991 p.303, no.1117, pl.153; Villing et al 2013-2015 (ORC) GD.1215 phase 2;
|
|
26.2.70
|
CVA Reading 1, p.38, pl. 23, no.12a-b; Lemos 1991 p.306, no.1227, pl.159; Villing et al 2013-2015 (ORC) GD.2024 phase 2;
|
|
26.2.71
|
CVA Reading 1, p.38, pl. 23, no.13a-b; Lemos 1991 p.306, no.1228, pl.159; Villing et al 2013-2015 (ORC) GD.2026 phase 2;
|
|
26.2.72
|
CVA Reading 1,p.38, pl.23, no.14a-b, Lemos 1991 p.131, p.292, no.911, pl.121; Villing et al 2013-2015 (ORC) GD.1212 phase 2;
|
|